Empowering Your Journey to a Healthier You
Wellness Accelerator
Zealand Pharma on Thursday posted interim Phase Ib data for its investigational amylin analog petrelintide, touting strong weight reduction and a favorable tolerability…
Zealand Pharma believes its weight loss drug petrelintide could be comparable to glucagon like peptide-1 receptor agonists (GLP1-RAs) while providing…
The quest for increasingly effective and comprehensive obesity treatments has intensified, with pharmaceutical giants Boehringer Ingelheim and Zealand Pharma joining…
Biotech company Zealand Pharma reported early clinical trial results for their experimental drug ZP2929, a dual agonist targeting both the…
